Exodus Point Capital Management, LP Iovance Biotherapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$4.44 - $8.79 $1.56 Million - $3.09 Million	-351,237 Reduced 78.07%	98,663 $449,000
Q2 2023 Aug 10, 2023	BUY	$5.36 - $9.06 $2.41 Million - $4.08 Million	449,900 New	449,900 $3.17 Million
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $1.03 Million - $1.83 Million	183,354 Added 260.52%	253,733 $1.62 Million
Q3 2022 Nov 10, 2022	SELL	$9.53 - $13.11 $280,182 - $385,434	-29,400 Reduced 29.47%	70,379 $674,000
Q2 2022 Aug 19, 2022	SELL	$6.38 - $18.33 $246,114 - $707,098	-38,576 Reduced 27.88%	99,779 $1.1 Million
Q1 2022 May 13, 2022	BUY	$12.38 - $19.1 $1.52 Million - $2.35 Million	122,876 Added 793.82%	138,355 $2.3 Million
Q4 2021 Feb 11, 2022	SELL	$16.55 - $27.63 $236,251 - $394,418	-14,275 Reduced 47.98%	15,479 $295,000
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $465,974 - $609,773	-22,898 Reduced 43.49%	29,754 $734,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $859,807 - $1.74 Million	52,652 New	52,652 $1.37 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $1.31 Million - $2.4 Million	-45,671 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $855,079 - $1.53 Million	30,495 Added 200.94%	45,671 $2.12 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $1.99 Million - $2.6 Million	-71,744 Reduced 82.54%	15,176 $500,000
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $2.37 Million - $3.56 Million	86,920 New	86,920 $2.39 Million

320

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $958M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.